CVE-2015-3954

Description

Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated users root privileges on Port 23/TELNET by default. An unauthorized user could issue commands to the pump. Hospira recommends that customers close Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.

Category

9.8
CVSS
Severity: Critical
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.54%
Third-Party Advisory us-cert.gov
Affected: Hospira Plum A+ Infusion System
Affected: Hospira Plum A+3 Infusion System
Affected: Hospira Symbiq Infusion System
Published at:
Updated at:

References

Link Tags
https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01 mitigation third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2015-3954?
CVE-2015-3954 has been scored as a critical severity vulnerability.
How to fix CVE-2015-3954?
To fix CVE-2015-3954, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2015-3954 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2015-3954 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2015-3954?
CVE-2015-3954 affects Hospira Plum A+ Infusion System, Hospira Plum A+3 Infusion System, Hospira Symbiq Infusion System.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.